Brainsway (BRSYF) Short term Debt (2018)
Brainsway's (BRSYF) quarterly Short term Debt came in at $750000.0 in Q4 2018.
Powered by 
Analysis
Brainsway (BRSYF) Short term Debt (2018) Analysis & Trends
Brainsway (BRSYF) has reported Short term Debt for 1 consecutive years, with $750000.0 the latest figure, recorded in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn |